Heartflow, Inc. Common Stock (HTFL) is a publicly traded company in the Healthcare — Medical - Healthcare Information Services industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart.
Is Heartflow, Inc. Common Stock stock overvalued or undervalued in 2026?
As of October 28, 2026, Heartflow, Inc. Common Stock (HTFL) trades at $59.10 with no positive earnings over the last twelve months, according to Kaplio. No valuation verdict: it has no earnings to calculate a P/E from.
Kaplio overview: Heartflow, Inc. Common Stock
Market cap $5B · 52 weeks $20 – $59 (0 % below the high) · P/E no earnings · Dividend none · Next earnings November 12, 2026 · expected EPS $-0.10 · Closing price, Oct 28 · accounts published Aug 13.
- Valuation: P/Sales 18.9× (no earnings).
- Business: ROIC −24 % (weak).
- Balance sheet: Net debt/EBITDA 0.2× (solid).
- Earnings: 4 of 6 (uneven).
What would it be worth at its usual multiples?
No valuation verdict: it has no earnings to calculate a P/E from.
What matters in pharma: 3 of 4 pass
- ROIC −23.7 %, fails.
- R&D / Revenue 36.9 %, passes.
- Gross margin 76.8 %, passes, near the threshold.
- Net debt / EBITDA 0.2×, passes.
Against its peers (reference peers) — Heartflow, Inc. Common Stock: P/E —; EV/EBITDA —; ROIC -23.7 %; $5.1B. Waystar Holding Corp. (P/E 41.3×; EV/EBITDA 15.8×; ROIC 3.4 %; $5.5B), Doximity, Inc. (P/E 40.3×; EV/EBITDA 24.1×; ROIC 15.3 %; $6.1B), HealthEquity, Inc. (P/E 36.6×; EV/EBITDA 18.3×; ROIC 8.6 %; $8.4B).
Profitability
| Return on Equity | -42.25% |
| Return on Invested Capital | -23.67% |
| Return on Assets | -34.36% |
| Gross Margin | 80.08% |
| Operating Margin | -34.31% |
| Net Margin | -55.82% |
Financial Health
| Debt / Equity | 0.10 |
| Current Ratio | 5.08 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 21.62 |
Price Performance
| 1 month | +18.60% |
| 3 months | +134.24% |
| Year-to-date | +102.74% |
| 1 year | +57.52% |
Related companies: TEM · BTSG · HNGE · HQY · DOCS · WAY · PRVA
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of HTFL: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks